Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ...

Novo Nordisk (NVO) wins U.S. FDA nod for its Alhemo injection as a once-daily prophylaxis for bleeding prevention in patients ...

A seminar titled 'Hemophilia Awareness' was held here at Govt College Women University Sialkot (GCWUS) to educate ...

Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...

The U.S. Food and Drug Administration has approved Novo Nordisk's drug for the prevention or reduction of bleeding episodes ...

Key findings from 2024 focused on conditions like vaccine-induced immune thrombotic thrombocytopenia, immune thrombocytopenia ...

Plainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) ...

Novo Nordisk shares on the NYSE rose over 5% in premarket trading Monday, reversing some losses from Friday’s plunge that ...

A regional online seminar organized by UAE Hemophilia Group brought together 19 prominent experts and specialists of Hematology. The online event’s main goal was to create awareness on the challenges ...

Former Manila Mayor Isko Moreno Domagoso has channeled over P100 million from his talent fees to support various programs ...

Columnist Jennifer Lynne has made her annual in-person visit to her regional hemophilia treatment center, with some adjustments and news.